Epidemiology and outcome of sepsis in adult patients with Streptococcus pneumoniae infection in a Norwegian county 1993-2011: an observational study
- PMID: 27216810
- PMCID: PMC4877975
- DOI: 10.1186/s12879-016-1553-8
Epidemiology and outcome of sepsis in adult patients with Streptococcus pneumoniae infection in a Norwegian county 1993-2011: an observational study
Abstract
Background: Invasive pneumococcal disease (IPD) is responsible for significant mortality and morbidity worldwide. There are however few longitudinal studies on the changes in case fatality rate of IPD in recent years. We carried out a prospective observational study of patients with IPD in Nord Trøndelag county in Norway from 1993 to 2011 to study the clinical variables and disease outcome. The main outcome was all-cause mortality after 30 and 90 days.
Methods: Patients with positive blood cultures were registered prospectively by the microbiology laboratory and clinical variables were registered retrospectively from patients' hospital records. The severity of sepsis was assigned according to the 2001 International Sepsis Definition Conference criteria. The association between mortality and predictive factors was studied using a logistic regression model.
Results: The total number of patients was 414 with mean age of 67 years and 53 % were male. Comorbidity was assessed by the Charlson Comorbidity Index (CCI). A CCI-score of 0 was registered in 144 patients (34.8 %), whereas 190 had a score of 1-2 (45.9 %) and 80 (19.3 %) had a score ≥3. 68.8 % of the patients received appropriate antibiotics within the first 6 h. The 30-day mortality risk increased by age and was 3-fold higher for patients aged ≥80 years (24.9, 95 % CI 16.4-33.4 %) compared to patients aged <70 (8.0, 95 % CI 3.5-12.4 %). 110 patients, (26.6 %) had severe sepsis and 37 (8.9 %) had septic shock. The 30 day all-cause mortality risk for those with sepsis without organ failure was 5.4 % (95 % CI 2.7-8.0 %), 20.2 % (95 % CI 13.5-27.4 %) for those with severe sepsis and 35.0 % (95 % CI 21.6-49.0 %) for those with septic shock. The mortality risk did not differ between the first and the second halves of the study period with a 30-day mortality risk of 13.5 % (95 % CI 7.9-19.2 %) for 1993-2002 versus 11.8 % (95 % CI 8.2-15.3 %) for 2003-2011.
Conclusion: IPD carries a high mortality despite early and appropriate antibiotics in most cases. We found no substantial decrease in case fatality rate during the study period of 18 years. Older age and higher severity of disease were important risk factors for death in IPD.
Keywords: Bacteremia; Sepsis; Streptococcus pneumoniae.
Similar articles
-
Epidemiology and outcome of Staphylococcus aureus bloodstream infection and sepsis in a Norwegian county 1996-2011: an observational study.BMC Infect Dis. 2015 Mar 4;15:116. doi: 10.1186/s12879-015-0849-4. BMC Infect Dis. 2015. PMID: 25887177 Free PMC article.
-
Clinical characteristics and risk factors for poor outcomes of invasive pneumococcal disease in pediatric patients in China.BMC Infect Dis. 2024 Jun 19;24(1):602. doi: 10.1186/s12879-024-09493-9. BMC Infect Dis. 2024. PMID: 38898407 Free PMC article.
-
Gastrointestinal symptoms in invasive pneumococcal disease: a cohort study.BMC Infect Dis. 2020 Jul 6;20(1):479. doi: 10.1186/s12879-020-05211-3. BMC Infect Dis. 2020. PMID: 32631331 Free PMC article.
-
Streptococcus Pneumoniae septic arthritis in adults in Bristol and Bath, United Kingdom, 2006-2018: a 13-year retrospective observational cohort study.Emerg Microbes Infect. 2021 Dec;10(1):1369-1377. doi: 10.1080/22221751.2021.1945955. Emerg Microbes Infect. 2021. PMID: 34151740 Free PMC article.
-
Clinical outcome after a totally implantable venous access port-related infection in cancer patients: a prospective study and review of the literature.Medicine (Baltimore). 2012 Nov;91(6):309-318. doi: 10.1097/MD.0b013e318275ffe1. Medicine (Baltimore). 2012. PMID: 23117849 Review.
Cited by
-
Septic Shock and Purpura Fulminans Due to Streptococcus pneumoniae Bacteremia in an Unvaccinated Immunocompetent Adult: Case Report and Review.Am J Case Rep. 2020 Jun 9;21:e923266. doi: 10.12659/AJCR.923266. Am J Case Rep. 2020. PMID: 32513908 Free PMC article. Review.
-
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine administered in a prime-boost regimen among Chinese infants: a randomized, double blind phase III clinical trial.Hum Vaccin Immunother. 2022 Dec 31;18(1):2019498. doi: 10.1080/21645515.2021.2019498. Epub 2022 Feb 22. Hum Vaccin Immunother. 2022. PMID: 35192784 Free PMC article. Clinical Trial.
-
Nano-Biotechnology for Bacteria Identification and Potent Anti-bacterial Properties: A Review of Current State of the Art.Nanomaterials (Basel). 2023 Sep 10;13(18):2529. doi: 10.3390/nano13182529. Nanomaterials (Basel). 2023. PMID: 37764558 Free PMC article. Review.
-
Venoarterial extracorporeal membrane oxygenation support for neonatal and pediatric refractory septic shock: more than 15 years of learning.Eur J Pediatr. 2018 Aug;177(8):1191-1200. doi: 10.1007/s00431-018-3174-2. Epub 2018 May 24. Eur J Pediatr. 2018. PMID: 29799085
-
Factors Associated With Severe Nonmeningitis Invasive Pneumococcal Disease in Adults in France.Open Forum Infect Dis. 2019 Nov 30;6(12):ofz510. doi: 10.1093/ofid/ofz510. eCollection 2019 Dec. Open Forum Infect Dis. 2019. PMID: 31868865 Free PMC article.
References
-
- Chavanet P. Pneumococcus infections: is the burden still as heavy? Med et mal infect. 2012;42(4):149–153. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical